neuroscience

3rd Annual Blood-Brain Barrier Summit

https://pharmaphorum.com/events/3rd-annual-blood-brain-barrier-summit/

The 3rd Annual Blood-Brain Barrier Summit Returns in August 2021

https://pharmaphorum.com/partner-content/the-3rd-annual-blood-brain-barrier-summit-returns-in-august-2021/

Merck builds in CNS diseases with $576m Calporta buy

https://pharmaphorum.com/news/merck-builds-in-cns-diseases-with-576m-calporta-buy/

Gut-Brain Axis 2018

https://pharmaphorum.com/events/gut-brain-axis-2018/

Celgene pursues neuro breakthrough with $150m Prosena deal

https://pharmaphorum.com/news/celgene-pursues-neuro-breakthrough-150m-prosena-deal/

SMi’s Pain Therapeutics Conference

www.pain-therapeutics.co.uk/phphorum

Pfizer axes Alzheimer’s and Parkinson’s research

https://pharmaphorum.com/news/pfizer-axes-rd-new-alzheimers-parkinsons-drugs/

Looking back, looking forward – Janssen’s 60 years on the psychiatry horizon

https://pharmaphorum.com/views-and-analysis/janssen-mental-health-psychiatry/

Takeda retains UK investment with new neuroscience company Cerevance

https://pharmaphorum.com/news/takeda-retains-uk-investment-new-neuroscience-company-cerevance/

Close in 10 seconds

Pharmaphorum.com

Search